Detected ·
Biossil
——
Biossil raised US$43M led by Founders Fund and OpenAI. The company uses proprietary GEMOD technology to identify patient subgroups for discontinued drugs and advance them through targeted clinical trials.
- Website
- www.biossil.co
- linkedin.com/company/biossil-ai
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-20 18:09:41 UTC
- Signal ID
- 218d1d75-faa9-4ae8-8dab-26a6335272fb
As the API returns it
{
"id": "218d1d75-faa9-4ae8-8dab-26a6335272fb",
"created_at": "2026-04-20T18:09:41.046907Z",
"company_name": "Biossil",
"company_website_url": "www.biossil.co",
"company_linkedin_url": "https://www.linkedin.com/company/biossil-ai",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Biossil raised US$43M led by Founders Fund and OpenAI. The company uses proprietary GEMOD technology to identify patient subgroups for discontinued drugs and advance them through targeted clinical trials.*"
}